Medigef 250 Tablet is indicated to the patients dealing with non-small cell lung cancer. Cancer of this type tends to spread quickly in other parts of the body. Medigef 250 Tablet travels through the bloodstream and effectively destroys cancerous cells of the lung and other parts of the body. Medigef 250 Tablet is a ' tyrosine kinase inhibitor (TKI)', that stops the uncontrolled growth and spread of cancerous cells. It acts by stopping the abnormal protein action that is responsible for the multiplication of cancerous cells. Whenever a new healthy cell is formed, it undergoes a usual process of maturity. Cancerous cells form new cells more quickly, so Medigef 250 Tablet targets cancerous cells and blocks the action of Tyrosine kinase enzymes (responsible for causing cancer). It also decreases the blood supply to cancer tumors to slow down the growth of the tumor. In this way, Medigef 250 Tablet stops the production, spread and growth of cancerous cells in the body.

FAQs

What is the use of Medigef 250 Tablet ?

Medigef 250 Tablet is used to treat non-small cell lung cancer.

How does Medigef 250 Tablet work?

Medigef 250 Tablet works by stopping the action of an abnormal protein that causes the multiplication of cancerous cells. Thereby, it prevents the spread of cancerous cells.

What are the first signs of lung cancer?

The most common sign of lung cancer is a cough that lasts long and gets worse with time. Sometimes, a patient may notice blood in the cough. Chest pain is also a sign of lung cancer followed by coughing.

What should I avoid while taking Medigef 250 Tablet ?

It is suggested to avoid taking an antacid or stomach acid-reducing medicine within 6 hours after taking Medigef 250 Tablet as it may make the medicine less effective if taken simultaneously.

I am a diabetic person, can I take Medigef 250 Tablet ?

Medigef 250 Tablet is safe to be taken by a diabetic person. However, take Medigef 250 Tablet only after asking a doctor as they may adjust the dosing according to the patient's condition.